Motoyama K - Search Results

1

Lovastatin decreases mortality and improves liver functions in fulminant hepatic failure from 90% partial hepatectomy in rats.

Cai SR, Motoyama K, Shen KJ, Kennedy SC, Flye MW, Ponder KP. Cai SR, et al. Among authors: motoyama k. J Hepatol. 2000 Jan;32(1):67-77. doi: 10.1016/s0168-8278(00)80191-9. J Hepatol. 2000. PMID: 10673069

2

Effect of Ca2+ agonists in the perfused liver: determination via laser scanning confocal microscopy.

Motoyama K, Karl IE, Flye MW, Osborne DF, Hotchkiss RS. Motoyama K, et al. Am J Physiol. 1999 Feb;276(2):R575-85. doi: 10.1152/ajpregu.1999.276.2.R575. Am J Physiol. 1999. PMID: 9950939

3

Analysis of donor-specific unresponsiveness to rat allografts by nondepleting anti-CD4 monoclonal antibody (RIB 5/2) plus donor antigen.

Motoyama K, Lehmann M, Flye MW. Motoyama K, et al. Transplant Proc. 1999 Feb-Mar;31(1-2):1237-8. doi: 10.1016/s0041-1345(98)02112-5. Transplant Proc. 1999. PMID: 10083552 No abstract available.

4

The kinetics of tolerance induction by nondepleting anti-CD4 monoclonal antibody (RIB 5/2) plus intravenous donor alloantigen administration.

Motoyama K, Arima T, Yu S, Lehmann M, Flye MW. Motoyama K, et al. Transplantation. 2000 Jan 27;69(2):285-93. doi: 10.1097/00007890-200001270-00015. Transplantation. 2000. PMID: 10670640

5

Tolerance to heart and kidney grafts induced by nondepleting anti-CD4 monoclonal antibody (RIB 5/2) versus depleting anti-CD4 monoclonal antibody (OX-38) with donor antigen administration.

Motoyama K, Arima T, Lehmann M, Flye MW. Motoyama K, et al. Surgery. 1997 Aug;122(2):213-9; discussion 219-20. doi: 10.1016/s0039-6060(97)90011-8. Surgery. 1997. PMID: 9288125

6

Intrathymic alloantigen-mediated, tolerant, completely major histocompatibility complex-mismatched mouse hearts are specifically rejected by adoptively transferred anti-class I L(d+)-specific 2C cells.

Otomo N, Motoyama K, Yu S, Shimizu Y, Margenthaler J, Tu F, Flye MW. Otomo N, et al. Among authors: motoyama k. Surgery. 2000 Aug;128(2):206-12. doi: 10.1067/msy.2000.107377. Surgery. 2000. PMID: 10922993

7

Intrathymic alloantigen-mediated tolerant, completely MHC-mismatched mouse hearts are specifically rejected by adoptively transferred in vitro-sensitized anti-class I L(d+)-specific 2C cells.

Otomo N, Motoyama K, Yu S, Shimizu Y, Margenthaler JA, Tu F, Flye MW. Otomo N, et al. Among authors: motoyama k. Transplant Proc. 2001 Feb-Mar;33(1-2):159-60. doi: 10.1016/s0041-1345(00)01954-0. Transplant Proc. 2001. PMID: 11266758 No abstract available.

8

Organ transplant specificity of tolerance to skin grafts with heart or kidney grafts plus nondepleting anti-CD4 monoclonal antibody (RIB 5/2) and intravenous donor alloantigen administration.

Otomo N, Margenthaler JA, Motoyama K, Arima T, Shimizu Y, Lehmann M, Flye MW. Otomo N, et al. Among authors: motoyama k. J Surg Res. 2001 Jun 1;98(1):59-65. doi: 10.1006/jsre.2001.6169. J Surg Res. 2001. PMID: 11368539

9

Pretransplant intrathymic inoculation of donor antigen combined with FK506 treatment: prolongation of survival of cardiac, but not renal, allografts in rats.

Motoyama K, Kamei T, Arima T, Ueki M, Hirano T, Nakafusa Y, Tanaka M. Motoyama K, et al. World J Surg. 1995 Mar-Apr;19(2):299-302. doi: 10.1007/BF00308644. World J Surg. 1995. PMID: 7538717

10

The combined use of prostaglandin I2 analogue (OP-2507) and thromboxane A2 synthetase inhibitor (OKY-046) strongly inhibits atherosclerosis of aortic allografts in rats.

Hirano T, Nakafusa Y, Kawano R, Motoyama K, Arima T, Sugitani A, Tanaka M. Hirano T, et al. Among authors: motoyama k. Surgery. 2001 May;129(5):595-605. doi: 10.1067/msy.2001.112595. Surgery. 2001. PMID: 11331452

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

330 results

Search Page

Filters